Week 3 Flashcards

1
Q

What is pharmacokinetics?

A

What the body does to the drug: absorption, distribution, metabolism, excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Things that affect pharmacokinetics:

A
Age
Pregnancy 
Hepatic/renal disease 
Drug interactions
Ethnicity 
Metabolism
GI surgery
Nutritional status
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the fraction of unchanged drug teaching systemic circulation?

A

Bioavailability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Rate at which drug leaves site of administration and passes to systemic circulation. How drug enters the body.

A

Absorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Factors affecting absorption:

A
Presence/absence of food in stomach
Blood flow to area
Formulation of drug
Size of molecule 
Ionization 
Cellular environment
Lipophilicity
Mechanism of absorption: passive diffusion or active transport
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

A drug that is more basic will be absorbed where:

A

A more basic environment such as small intestines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

A drug that is more acidic will be absorbed:

A

In a more acidic environment like the stomach

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

This enhances renal clearance of drugs during toxicity.

A

Ion (drug) trapping

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

With an acidic drug overdose what would you give for ion trapping?

A

Sodium bicarbonate to make urine more alkaline and prevent reabsorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

For a basic drug overdose, what would you give?

A

Ammonium chloride to make more urine more acidic and prevent reabsorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Most drugs are absorbed through the GI tract by:

A

Passive diffusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How the drug will distribute through the body:

A

Volume of distribution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Volume of distribution depends on:

A

Solubility
Charge
Size

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Larger Vd will concentrate where:

A

In tissues of the body- lipophilic drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Smaller Vd concentrates:

A

In the plasma- hydrophilic drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Properties affecting distribution:

A

Molecular size
Lipid solubility
Ph of environment
Ionization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

A high degree of plasma protein binding can result in:

A

Restricted drug distribution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Active drugs being made less active to be excreted:

A

Metabolism/biotransformation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Metabolism occurs primarily here:

A

Liver

But also: intestines, skin, lungs, kidney, and brain

20
Q

An inactive drug that becomes active with metabolism:

A

Prodrug

21
Q

Phase I reactions occur through:

A

Oxidation (most common), reduction, and hydrolysis

22
Q

What system does phase I metabolism occur:

A

Most often cytochrome 450 system

23
Q

Goal of Phase I reactions:

A

Parent drug converted to a drug more easily excreted/water soluble.

24
Q

With aging the livers capacity for metabolism through the P450 system is ___

A

Reduced by 30%

This drugs metabolized through this system reach higher levels and have prolonged half lives in the elderly

25
Q

Explain CYP450 enzyme induction:

A

An inducing agent can increase the metabolism of another drug, resulting in the effect of the second drug being reduced. This can lead to therapeutic failure of the second drug.

26
Q

Explain CYP450 enzyme inhibition:

A

An inhibiting drug can decrease the rate of metabolism of another drug, causing the second drugs level to rise and possibly result in harmful or reverse effect.

27
Q

Phase II reactions are these types of reactions:

A

Glucurondiation
Acetylation
Sulfation

28
Q

Phase II causes drugs to:

A

Conjugate with another substance to make drug more water soluble and easier to excrete.

29
Q

Patients deficient in acetylation capacity (slow acetylators) may have:

A

Prolonged or toxic responses to normal doses of certain drugs bc of decreased rates of metabolism .

30
Q

Factors affecting metabolism:

A
Age
Gender
Drug tolerance
Co-morbidities
Drug-drug interactions 
Genetic differences
Diet and environment factors
31
Q

Primary site of excretion is:

A

Kidney

32
Q

Filtration works well for:

A

Hydrophilic, ionized compounds

33
Q

Process of drugs being transferred from inside to outside the body.

A

Excretion

34
Q

What types of drugs use biliary excretion:

A

Usually larger molecular weight drugs- erythromycin

35
Q

Some ___ soluble drugs will get passively reabsorbed into circulation .

A

Lipid

36
Q

Factors affecting renal excretion:

A

Renal function
Protein binding
Renal disease

37
Q

If creating is elevated then creative clearance is

A

Decreased - drug will not be as easily excreted and there is an increased potential for toxicity

38
Q

At a steady state, rate of clearance should be:

A

Equal to the amount of drug taken in

39
Q

Time it takes the peak drug level in the bloodstream to drop by half after elimination from the body.

A

Half-life

40
Q

High enough to maintain effect, low enough to prevent toxicity.

A

Steady state

41
Q

Refers more broadly to the genome-wide (or an individuals entire DNA sequence) effects on drug therapy

A

Pharmacogenomics

42
Q

Refers to a single or a few gene variations (called polymorphisms)

A

Pharmacogenetics

43
Q

Poor metabolizers:

A

Slowly metabolize drug causing increase of drug in system

44
Q

Poor metabolizers should have an increase or decrease in dosage?

A

Decrease

45
Q

Ultra-rapid metabolizers:

A

Have an increased metabolism of drug causing therapeutic failure of drug

46
Q

Ultra-rapid metabolizers need an increase or decrease in dosage?

A

Increase in dose to have effect

47
Q

What will happen with a prodrug and an ultra rapid metabolizers?

A

Will become more active and become potentially toxic